Delisting risk
20/20 Biolabs
Blood testing for cancer screening and inflammation tracking, plus laboratory services for diagnostic developers.
$0.6332
After-hours close+0.00 (+0.54%)
At close$0.6298(+1.63%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 2.45%300.4K sharesInsiders 11.53%1.41M sharesOther 86.02%10.54M shares
Shares outstanding 12.25M · Float 8.13M · 66.4% free float
Institutions13F, as of Mar 31, 2026
7 holders · 300.4K shares · 7 new positions · 7 increased · 0 reduced · 0 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Cresset Asset Management, LLC | 264.4K | 2.16% | +264.4Knew | May 15, 2026 |
| Citadel Advisors LLC | 16.2K | 0.13% | +16.2Knew | May 15, 2026 |
| XTX Topco Ltd | 10.3K | 0.08% | +10.3Knew | May 15, 2026 |
| UBS Group AG | 8.3K | 0.07% | +8.3Knew | May 5, 2026 |
| Mai Capital Management | 1.0K | 0.01% | +1.0Knew | May 15, 2026 |
| Toth Financial Advisory Corp | 157 | 0.00% | +157new | Apr 16, 2026 |
| Allworth Financial LP | 30 | 0.00% | +30new | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Jonathan M Cohen | 16.80% | 1.83M | 13D | Mar 10, 2026 ↗ |
| Streeterville Capital LLC | 9.90% | 543.7K | 13G | Feb 25, 2026 ↗ |
| Full Succeed International Limited | 6.30% | 651.5K | 13G | Mar 10, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Jonathan M. Cohen | director, 10 percent owner, officer: Chief Executive Officer | 1.37M | 11.15% | Feb 19, 2026 |
| John Woodson Rollins | director | 24.1K | 0.20% | Feb 24, 2026 |
| John G. Compton | director | 14.3K | 0.12% | Feb 23, 2026 |
| Richard M. Cohen | director | 7.7K | 0.06% | Feb 23, 2026 |
| Michael A. Ross | director | 31 | 0.00% | Feb 23, 2026 |
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.